National holding platform, provincial project companies, and separate operating companies for hospital, university, hospitality, utilities, farms, retail, data, and advanced medicine.
Clinical, legal, ethical, and public-benefit governance from day one.
National holding platform, provincial project companies, and separate operating companies for hospital, university, hospitality, utilities, farms, retail, data, and advanced medicine.
Clinical, legal, ethical, and public-benefit governance from day one.
Clinical governance board, advanced therapies ethics committee, patient safety, infection control, legal, risk, audit, procurement, data governance, research ethics, and community benefit agreements.
Hospital licensing, medical education accreditation, SAHPRA, HPCSA, nursing council, pharmacy council, laboratory accreditation, clinical trial approval, medical device compliance, radiation controls, POPIA, environmental approvals, water rights, waste permits, energy approvals, zoning, and visiting-doctor credentialing.
Advanced therapy, costing, and partner claims require evidence before investor release.
Gene therapy is treated as a Tygan-owned or Tygan-controlled patent platform from project start. Medical pathways remain subject to clinical governance, SAHPRA, ethics, POPIA, patient consent, scientific validation, and independent legal review.
